Table 1.
Chi square test of different clinicopathological parameters and biomarkers of p53 and HOXA5
| P53 | HOXA5 | |||||
|---|---|---|---|---|---|---|
| (+) | (-) | P value | (+) | (-) | P value | |
| Age (year) | ||||||
| <65 | 9 (29%) | 22 (71%) | 0.845 | 17 (55%) | 14 (45%) | 0.009 |
| ≧65 | 12 (30%) | 28 (70%) | 9 (23%) | 31 (77%) | ||
| Gender | ||||||
| Male | 17 (35%) | 31 (65%) | 0.218 | 15 (31%) | 33 (69%) | 0.239 |
| Female | 4 (17%) | 19 (83%) | 11 (48%) | 12 (52%) | ||
| Type | ||||||
| SCC | 11 (61%) | 7 (39%) | < 0.001 | 3 (17%) | 15 (83%) | 0.036 |
| AdCa | 10 (19%) | 43 (81%) | 23 (43%) | 30 (57%) | ||
| Differentiation | ||||||
| Well | 1 (13%) | 7 (87%) | 0.406 | 2 (25%) | 6 (75%) | 0.141 |
| Moderate | 12 (29%) | 29 (71%) | 19 (46%) | 23 (54%) | ||
| Poor | 8 (36%) | 14 (64%) | 5 (23%) | 17 (77%) | ||
| Stage | ||||||
| I, II | 17 (31%) | 38 (69%) | 0.909 | 21 (38%) | 34 (62%) | 0.927 |
| III, IV | 4 (25%) | 12 (75%) | 5 (31%) | 11 (69%) | ||
SCC = Squamous cell carcinoma; AdCa = Adenocarcinoma.
Data are shown as number (percentage).